Navigation Links
Varian Medical Systems Appoints Deepak "Dee" Khuntia M.D. Vice President of Medical Affairs

PALO ALTO, Calif., March 28, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the appointment of Deepak "Dee" Khuntia, M.D., to vice president, Medical Affairs.  He will report to Kolleen Kennedy , corporate senior vice president and president of Varian's Oncology Systems business, the world's leading provider of radiotherapy technology for the treatment of cancer.  Khuntia will partner closely with Varian's Quality & Regulatory teams, providing clinical and scientific guidance in all areas of clinical risk, safety reviews, adverse experience reporting, product life cycle reviews and clinical protocol design.

"Dee brings a wealth of directly relevant experience to this important role," said Kennedy.  "He is a well-reputed thought leader in the field of oncology with a special interest in advanced radiation delivery techniques as well as medical informatics, continuing education, and healthcare policy.  With his broad experience and strong leadership skills, I am confident that he will help us maximize the clinical potential of our product development efforts and collaborative research partnerships with a strong focus on healthcare economics."

Khuntia has led multiple national and international clinical trials designed to advance the standards of care in the treatment of brain, lung, head and neck, and prostate cancer.  A widely published clinical researcher, his presentations and papers have spanned a broad range of topics including radiotherapy, radiosurgery, and imaging techniques in the treatment of cancer. Passionate about education and broad scale quality cancer care delivery, he has lectured worldwide helping to bridge the knowledge gap that exists with the recent surge of advanced radiation techniques.

Khuntia joined Varian earlier this month after serving two years as director of research and education for a large private practice in the San Francisco Bay area.  Prior to that, he practiced at the University of Wisconsin in Madison, where he served in many leadership roles, including Residency Program Director, Vice-Chair of Radiation Oncology Outreach, and Course Director for Neoplastic Diseases at the University of Wisconsin School of Medicine and Public Health. 

Khuntia holds a medical degree from the University Of Illinois College Of Medicine, and completed his radiation oncology residency at the Cleveland Clinic Foundation.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit or follow us on Twitter.


Varian Medical Systems
Meryl Ginsberg , 650.424.6444

SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
4. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
5. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
6. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
7. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
8. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2012
9. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
10. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
11. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of Stock through Calendar Year 2013
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back ... to choose from, the possibilities are endless. Users have full control over angle of ... Pulse masking effects, users are sure to get heads to turn. , ProPanel: Pulse ...
(Date:11/27/2015)... ... , ... According to an article published November 15th by ABC ... security in light of the recent terrorist attacks in Paris, other cities are taking ... attack from reaching U.S. soil. Especially around special events that may be high-profile in ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
(Date:11/27/2015)... ... 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over ... More than 3.7 billion people under the age of 50 – or 67% of ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
Breaking Medicine News(10 mins):